Toshiki Tomori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Toshiki Tomori has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Françoise Arnaud
NeuroTrauma Department, Naval Medical Research Center (NMRC), Silver Spring, MD 20910, USA
2 shared publications - Kohsuke Teranishi
Naval Medical Research Center
2 shared publications - Richard Michael McCarron
Operational and Undersea Medicine Directorate, Naval Medical Research Center, Silver Spring, Maryland, USA
2 shared publications - Anne McKeague
Naval Medical Research Center
1 shared publication - Daniel Freilich
Hematomimetics Program, Trauma and Resuscitative Medicine Department, Naval Medical Research Center, Silver Spring, Maryland, USA
1 shared publication - Daniel Hupalo
Uniformed Services University of Health Sciences, Bethesda, MD
1 shared publication
Latest Publications
- 1 January 2010
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 21 (1) , 20-27
Evaluation of coagulation stages of hemorrhaged swine: comparison of thromboelastography and rotational elastometry
Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) assesses blood viscoelastic properties and clotting kinetics that can be measured by Haemoscope TEG and Pentapharm ROTEM devices using slightly different methodologies. These devices were compared by measuring blood samples associated with various degrees of coagulopathy. Blood samples, collected from swine undergoing three types of severe injury and resuscitation protocol resulting in normal, hypercoagulopathy, and hypocoagulopathy, were assessed with TEG or ROTEM before the surgical procedures, and after injury, fluid resuscitation, and simulated hospital phase. Standard clotting parameters were compared by Student's t-test at a significance of a P value less than 0.05. Regression analysis indicated a positive correlation between TEG and ROTEM for reaction time (R), clotting rate (K), and maximum amplitude (Ma) parameters. With samples of normal coagulation, R (440 +/- 136 vs. 391 +/- 73 s), K (99 +/- 39 vs. 81 +/- 20 s), and Ma (74 +/- 4 vs. 69 +/- 5 mm) were higher, whereas (alpha) (68 +/- 8 vs. 75 +/- 3 mm) was lower with TEG than ROTEM, respectively; a P value is less than 0.05. The magnitude of changes from baseline in hypercoagulable or hypocoagulable samples due to level of injury was equivalent with TEG and ROTEM indicating comparable use of the instruments. However, when samples were extremely hypocoagulopathic due to resuscitation fluid, the TEG values could not be readily determined. Overall, TEG readings were higher than ROTEM readings; this disparity between the two instruments was attenuated with hypercoaguable samples. Both devices yielded similar information regarding the status of coagulation related to trauma. Because of operating characteristics, the same instrument should be used for monitoring the same patient or study.
- 1 January 2010
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 21 (1) , 20-27
Evaluation of coagulation stages of hemorrhaged swine: comparison of thromboelastography and rotational elastometry
Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) assesses blood viscoelastic properties and clotting kinetics that can be measured by Haemoscope TEG and Pentapharm ROTEM devices using slightly different methodologies. These devices were compared by measuring blood samples associated with various degrees of coagulopathy. Blood samples, collected from swine undergoing three types of severe injury and resuscitation protocol resulting in normal, hypercoagulopathy, and hypocoagulopathy, were assessed with TEG or ROTEM before the surgical procedures, and after injury, fluid resuscitation, and simulated hospital phase. Standard clotting parameters were compared by Student's t-test at a significance of a P value less than 0.05. Regression analysis indicated a positive correlation between TEG and ROTEM for reaction time (R), clotting rate (K), and maximum amplitude (Ma) parameters. With samples of normal coagulation, R (440 +/- 136 vs. 391 +/- 73 s), K (99 +/- 39 vs. 81 +/- 20 s), and Ma (74 +/- 4 vs. 69 +/- 5 mm) were higher, whereas (alpha) (68 +/- 8 vs. 75 +/- 3 mm) was lower with TEG than ROTEM, respectively; a P value is less than 0.05. The magnitude of changes from baseline in hypercoagulable or hypocoagulable samples due to level of injury was equivalent with TEG and ROTEM indicating comparable use of the instruments. However, when samples were extremely hypocoagulopathic due to resuscitation fluid, the TEG values could not be readily determined. Overall, TEG readings were higher than ROTEM readings; this disparity between the two instruments was attenuated with hypercoaguable samples. Both devices yielded similar information regarding the status of coagulation related to trauma. Because of operating characteristics, the same instrument should be used for monitoring the same patient or study.
- 20 August 2008
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 36 (10) , 1708-1713
Exothermic Reaction in Zeolite Hemostatic Dressings: QuikClot ACS and ACS+®
Background Zeolites have hemostatic properties used to stop bleeding in severe hemorrhage. Manufactured QuikClot® is an approved zeolite-based hemostatic agent for battlefield use. The exothermic reaction associated with QuikClot as loose granules or as granules packaged in a mesh bag has potential burn effects; this led to the development of a formulation of “cooler” non-exothermic QuikClot. The goal of this study was to compare the elevation of temperature of these formulations upon contact with blood. Methods Following full transection of the femoral vasculature, anesthetized Yorkshire pigs (n = 15) (28.8 ± 1.5 kg) were hemorrhaged for 2 min and treated with 100 g of bagged QuikClot (Advanced Clotting Sponge (ACS) (n = 4)) or a modified non-exothermic formulation (ACS+ (n = 11)). Vital signs and temperature at the dressing/tissue interface were continuously recorded for 3 h. Additional procedures were used to examine effects of different ratios of blood to zeolite on temperature elevation. Results Total post-treatment blood loss was comparable for ACS+_E and ACS_E groups (overall average: 18.6 ± 10.5% EBV). Temperature recorded at the dressing/tissue interface was significantly lower with ACS+ vs. ACS (40.3 ± 1.8 vs. 61.4 ± 10.7 °C, respectively, p < 0.01) and was 3.2 ± 2.6 °C higher than rectal temperature (38.0 ± 0.7 °C, p < 0.01). Survival at endpoint (7/11 vs. 4/4) and average survival time (134 ± 64 vs. 180 min) were greater for both ACS+ and ACS in comparison to Standard Dressing. The wound temperature with ACS was reduced with greater blood to product ratios and this pattern was paralleled with in vitro measurements. Conclusions The lower heat release with ACS+ compared to ACS was confirmed in an animal model and ACS+ had similar efficacy in arresting bleeding when compared to Standard Dressing.
- 20 August 2008
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 36 (10) , 1708-1713
Exothermic Reaction in Zeolite Hemostatic Dressings: QuikClot ACS and ACS+®
Background Zeolites have hemostatic properties used to stop bleeding in severe hemorrhage. Manufactured QuikClot® is an approved zeolite-based hemostatic agent for battlefield use. The exothermic reaction associated with QuikClot as loose granules or as granules packaged in a mesh bag has potential burn effects; this led to the development of a formulation of “cooler” non-exothermic QuikClot. The goal of this study was to compare the elevation of temperature of these formulations upon contact with blood. Methods Following full transection of the femoral vasculature, anesthetized Yorkshire pigs (n = 15) (28.8 ± 1.5 kg) were hemorrhaged for 2 min and treated with 100 g of bagged QuikClot (Advanced Clotting Sponge (ACS) (n = 4)) or a modified non-exothermic formulation (ACS+ (n = 11)). Vital signs and temperature at the dressing/tissue interface were continuously recorded for 3 h. Additional procedures were used to examine effects of different ratios of blood to zeolite on temperature elevation. Results Total post-treatment blood loss was comparable for ACS+_E and ACS_E groups (overall average: 18.6 ± 10.5% EBV). Temperature recorded at the dressing/tissue interface was significantly lower with ACS+ vs. ACS (40.3 ± 1.8 vs. 61.4 ± 10.7 °C, respectively, p < 0.01) and was 3.2 ± 2.6 °C higher than rectal temperature (38.0 ± 0.7 °C, p < 0.01). Survival at endpoint (7/11 vs. 4/4) and average survival time (134 ± 64 vs. 180 min) were greater for both ACS+ and ACS in comparison to Standard Dressing. The wound temperature with ACS was reduced with greater blood to product ratios and this pattern was paralleled with in vitro measurements. Conclusions The lower heat release with ACS+ compared to ACS was confirmed in an animal model and ACS+ had similar efficacy in arresting bleeding when compared to Standard Dressing.